Consistently, overall pathway analysis revealed that the pathways affected in the tumors include the inflammatory pathways, estrogen signaling, the p53 pathway and histone modifications, reflecting a systemic nature of the disease that arises from the initial perturbations through the hepatitis component, as well as the hepatotoxins. The gene discussed is TP53; the disease is Hepatitis.